Product NDC: | 0071-0803 |
Proprietary Name: | Neurontin |
Non Proprietary Name: | GABAPENTIN |
Active Ingredient(s): | 100 mg/1 & nbsp; GABAPENTIN |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0071-0803 |
Labeler Name: | Parke-Davis Div of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020235 |
Marketing Category: | NDA |
Start Marketing Date: | 19931230 |
Package NDC: | 0071-0803-24 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0071-0803-24) |
NDC Code | 0071-0803-24 |
Proprietary Name | Neurontin |
Package Description | 100 CAPSULE in 1 BOTTLE (0071-0803-24) |
Product NDC | 0071-0803 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | GABAPENTIN |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19931230 |
Marketing Category Name | NDA |
Labeler Name | Parke-Davis Div of Pfizer Inc |
Substance Name | GABAPENTIN |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |